{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL13642&houseId=2®isteredInterest=false", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=HL13642&houseId=2®isteredInterest=false", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL13642&houseId=2®isteredInterest=false&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL13642&_page=0&houseId=2®isteredInterest=false", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL13642&houseId=2®isteredInterest=false", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL13642&houseId=2®isteredInterest=false", "items" : [{"_about" : "http://data.parliament.uk/resources/1289390", "AnsweringBody" : [{"_value" : "Treasury"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1289390/answer", "answerText" : {"_value" : "

The Government has been monitoring developments within the cryptoasset industry, including rising energy usage.<\/p>

<\/p>

The Cryptoasset Taskforce, comprising HM Treasury, the FCA, and the Bank of England, explores the impact of cryptoassets and assesses what, if any, regulation is required in response.<\/p>

<\/p>

The Government has already taken actions to signal a commitment to green technology, including a pledge to make Taskforce on Climate-related Financial Disclosures (TCFD) aligned financial disclosures mandatory across the economy by 2025, making the UK the first G20 nation to make such a commitment.<\/p>

<\/p>

Additionally, the Government has committed to the implementation of a green taxonomy. This will allow us to accelerate our work towards a greener financial sector, by providing a common definition for environmentally sustainable economy activities.<\/p>

The Government\u2019s objective for the upcoming COP26 climate change forum is to ensure that every professional financial decision takes climate change into account. The recovery from COVID-19 will determine the mitigation and adaptation pathways for decades to come. We must all do our part \u2013 we are working with the financial services sector, international financial institutions, central banks, regulators, and finance ministries to unlock rapid action at scale.<\/p>

<\/p>

The finance campaign will provide the conditions for a future that is genuinely greener, more resilient and more sustainable than the past. Action on finance underpins all the other COP campaigns: adaptation & resilience, energy transition, nature and zero-emission vehicles. Without the right levels of finance, the rest is not possible.<\/p>

<\/p>

The Government stands ready to respond to emerging risks or changes in the market and will continue to monitor how cryptoassets are being used in the UK.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4689", "label" : {"_value" : "Biography information for Lord Agnew of Oulton"} } , "answeringMemberPrinted" : {"_value" : "Lord Agnew of Oulton"} , "dateOfAnswer" : {"_value" : "2021-03-10", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2021-03-10T12:54:59.123Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "14"} , "answeringDeptShortName" : {"_value" : "Treasury"} , "answeringDeptSortName" : {"_value" : "Treasury"} , "date" : {"_value" : "2021-02-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cryptocurrencies"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government whether they plan to consider the energy use of cryptocurrencies as part of their preparations for COP26 and other international meetings on climate change during 2021; and what plans they have to investigate how cryptocurrencies affect their requirements for public and private sector organisations to meet climate change targets.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4533", "label" : {"_value" : "Biography information for Baroness Altmann"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Altmann"} ], "uin" : "HL13642"} , {"_about" : "http://data.parliament.uk/resources/1059620", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1059620/answer", "answerText" : {"_value" : "

On its website, Accelerated Evolution Biotechnologies Ltd presents a technology platform to identify promising peptides that can target cancer cells. All other information on multi-target toxin, (MuTaTo), which is a product combining several cancer-targeting peptides with a strong peptide toxin, which would be personalised to each patient and kill cancer cells specifically - is derived from interviews to newspapers. As no publication of the company\u2019s preliminary works (in vitro and in animals) is available from scientific journals, neither scientific experts nor the Medicines and Healthcare products Regulatory Agency (MHRA) is able to make any assessment of this therapy. The company claims that it is about to start clinical trials, but currently, no clinical trial with such a compound is registered in the European Union public register. If, in the future, the company wishes to apply for a Marketing Authorisation when results in patients become available, the MHRA will be able to assess the quality, safety and efficacy of this therapy and its risk and benefit for its use.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-02-26", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-02-26T13:36:54.473Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-02-12", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cancer: Medical Treatments"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what assessment they have made of the claims by Accelerated Evolution Biotechnologies of the potential for treating a wide range of cancers with a multi-target toxin treatment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/499", "label" : {"_value" : "Biography information for Lord Campbell-Savours"} } , "tablingMemberPrinted" : [{"_value" : "Lord Campbell-Savours"} ], "uin" : "HL13642"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }